Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 12-2009 | 09-2009 | 06-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 860 | 5,070 | 3,970 | 2,460 |
| Receivables | 0 | 640 | N/A | 7 | 120 |
| Other current assets | 0 | 150 | 240 | 253 | 410 |
| TOTAL | $0 | $1,650 | $5,310 | $4,230 | $2,990 |
| Non-Current Assets | |||||
| PPE Net | N/A | 520 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 17,250 | 0 | 0 | 0 |
| TOTAL | $N/A | $17,770 | $N/A | $N/A | $N/A |
| Total Assets | $0 | $19,050 | $5,450 | $4,530 | $4,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 1,930 | 0 | 890 | 950 |
| Accrued Expenses | 0 | 460 | N/A | 410 | 740 |
| Other current liabilities | 0 | 3,640 | N/A | 480 | 300 |
| TOTAL | $0 | $6,050 | $910 | $1,790 | $2,000 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 20 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $80 |
| Total Liabilities | $0 | $6,050 | $910 | $1,790 | $2,090 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 3 | 3 |
| Common Shares | 0 | 660 | N/A | 200 | 200 |
| Retained earnings | 0 | -320,360 | N/A | -314,670 | -315,340 |
| Other shareholders' equity | 0 | -100 | 4,530 | 0 | 0 |
| TOTAL | $0 | $13,000 | $4,530 | $2,730 | $1,970 |
| Total Liabilities And Equity | $0 | $19,050 | $5,440 | $4,520 | $4,060 |